department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Qvar Redihaler · pharmadog

pharmadog
drugs
Qvar Redihaler

drug

patient view →

Qvar Redihaler

Marketedupdated 2mo ago

by Teva Respiratory LLC

Approved

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 17 investigational indications.

indications

investigational

Asthma

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Qvar Redihaler

generic

beclomethasone dipropionate

MOA

Glucocorticoid receptor agonist

indication

Asthma

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Jul 17, 2031

~5.0 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (18)

Aug 19, 2041formulationUS 11583643
Aug 19, 2041formulationUS 11583643
May 5, 2041formulationUS 11957832
May 5, 2041formulationUS 11957832
Jul 21, 2039formulationUS 11559637
Jul 21, 2039formulationUS 11559637
Jan 25, 2039formulationUS 10792447
Jan 25, 2039formulationUS 10792447
Jan 26, 2038formulationUS 11395888
Jan 26, 2038formulationUS 11395888
Jan 26, 2038formulationUS 11793953
Jan 26, 2038formulationUS 11793953
Jan 26, 2038formulationUS 12296089
Jan 26, 2038formulationUS 12296089
Oct 21, 2031formulationUS 10188811
Oct 21, 2031formulationUS 10188811
Jul 17, 2031formulationUS 8931476
Jul 17, 2031formulationUS 8931476

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 3

tagApproval14 co-mentions · 4 sources
drugbeclomethasone dipropionate13 co-mentions · 4 sources
drugAerobec7 co-mentions · 4 sources

Trials studying Qvar Redihaler

phase3Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)completedn=1,714
phase3Functional Respiratory Imaging Study (DARWiIN)completedn=25
phase3Study in Adult Patients With Moderate to Severe Asthmacompletedn=78
phase3A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDcompletedn=3,433
phase3A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroidcompletedn=1,377
phase1Clinical Study to Evaluate the Safety, Tolerability and the Concentration of the BDP (Beclomethasone Dipropionate), Active Metabolite of BDP, FF( Formoterol Fumarate) and GB (Glycopyrronium Bromide), After Inhalation of CHF 5993 at Two Different Doses and QVAR®completedn=69
phase4Linear Growth Study (0476-097)(COMPLETED)completedn=360
phase2To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spraycompletedn=48

more trials →